There is accumulating evidence that leptin signalling might be involved in the development of several types of cancer, such as colon cancer, mammary cancer, prostate cancer, and epithelial ovarian cancer, as well as the development of several myeloid and lymphoid leukemic cell lines. This evidence concerns the gene LEP and breast cancer.